ActivX, Following Acquisition, Becomes Subsidiary of Kyorin Pharmaceutical

Feb 02, 2005

NEW YORK, Feb. 2 (GenomeWeb News) - Kyorin Pharmaceutical of Tokyohas completed its acquisition of ActivX Biosciences, La Jolla, Calif.-based ActivX said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

MyGene2 Resource Lets Families, Clinicians Searching for Molecular Diagnosis Share Data
LifeOmic Partners With Genomenon to Expedite Interpretation of Whole Genomes
Sentieon to Supply Genome Analysis Algorithms to Startup DNAstack
Liver Cancer Genomes Reveal Extent of Exposure to Mutagenic Herbal Remedy Compounds
Novacyt Raises €9.7M
FDA Accepts Myriad BRACAnalysis CDx Supplementary PMA for Lynparza in Breast Cancer Indication

The Scan

Re-Think on Science Standards

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Faster Efforts

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

Graves Wins Top Australian Science Prize

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

This Week in Cell

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.

Main menu